Back to search

Article

Investigation of the Effect of Thymoquinone on Egfr/FOXP3 Signaling Pathway in OVCAR3 Human Ovarian Adenocarcinoma Cells

2024-07-30

Abstract excerpt

<h4>Aim: </h4> In our study, the chemotherapeutic drug doxorubicin (Dox) and the natural anticancer property thymoquinone (TQ) were applied to OVCAR3 human ovarian adenocarcinoma cells and human skin keratinocyte cell line HaCat cells, and their cytotoxic effects were investigated through the EGFR/FOXP3 signaling pathway. <h4>Materials and Methods:</h4> In our study, different doses of thymoquinone and doxorubicin...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
0a3ed360-424d-58c5-a14e-76748e254442
DOI
10.20944/preprints202407.2359.v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Investigation of the Effect of Thymoquinone on Egfr/FOXP3 Signaling Pathway in OVCAR3 Human Ovarian Adenocarcinoma CellsDOI 10.20944/preprints202407.2359.v1
Select a neighboring publication to make it the new centre.